What the agencies reported
On 9 September 2020, WHO, UNICEF, the UN Population Division and the World Bank released new child mortality estimates. Global under-five deaths fell to a record low of 5.2 million in 2019, down from 12.5 million in 1990. However, agency surveys conducted during the pandemic found that service disruptions may erode that progress.
Key figures from the surveys
- A UNICEF survey across 77 countries found roughly 68% reported at least some disruption to child health checks and immunization services.
- 63% reported disruptions to antenatal checkups; 59% to postnatal care.
- A WHO survey across 105 countries found 52% reported disruptions in services for sick children and 51% in management of malnutrition.
- Countries identified as among the hardest hit included Afghanistan, Bolivia, Cameroon, the Central African Republic, Libya, Madagascar, Pakistan, Sudan and Yemen.
- Early Johns Hopkins University modelling cited by UNICEF suggested up to 6,000 additional child deaths per day could result from severe service disruption.
Reasons cited for disruption
Agencies listed caregiver avoidance of health facilities due to infection fear, transport restrictions, suspension or closure of facilities, reduced health-workforce availability including PPE shortages, and household financial strain.
Why travelers should note this
Disruption to routine immunization programs can reduce population-level protection against vaccine-preventable diseases such as measles, polio, diphtheria and pertussis. Reduced facility capacity may also affect the availability of routine maternal, newborn and pediatric services in affected regions, and can lengthen waits for non-emergency care.
Pharmacist's note
As a pharmacist with a background in pharmaceutical sciences, I read reports like this primarily as a signal about health-system capacity, not individual risk. Two general observations for information purposes:
First, immunization-coverage gaps described by WHO are a recognized precursor to outbreaks of vaccine-preventable illness, which is why national travel-health authorities commonly review routine vaccination status well before departure. Timing matters because some schedules require multiple doses over weeks.
Second, where facility access is constrained, continuity of existing medicines becomes harder to guarantee locally. Verifying product availability, documentation requirements and import rules for your own medicines in advance is a practical planning step.
This summary is public-health information only. It is not advice about any specific vaccine, medicine or dose. Decisions on vaccination, prophylaxis or treatment should be made with your own physician, pharmacist or a travel-medicine clinic, who can assess your itinerary, age, pregnancy status and medical history.
Source: WHO news release, 9 September 2020 (UN IGME "Levels and Trends in Child Mortality"). Figures reflect the reporting period and may since have changed; consult current WHO and national travel-health notices before travel.